Pharmacology and Toxicology Spring Seminar Program

Seminars are on Tuesdays, 4-4:50 p.m. in Sanger Hall, First Floor, Room 1-044 (unless otherwise noted). 

Date Speaker Topic
Jan. 16, 2018

Brant Isakson, Ph.D.
UVA Vivian Pinn Scholar
Associate Professor
Molecular Physiology and Biophysics
Resident Faculty, Robert M. Berne Cardiovascular Research Center
University of Virginia School of Medicine
Charlottesville, VA

Host:  Dr. Pin-Lan Li

Pannexin1 in the vasculature
Jan. 23, 2018

Frank Gupton, Ph.D.
Chair and Professor
Department of Chemical and Life    Science Engineering
Virginia Commonwealth University
Richmond, VA  23298

Host:  Dr. David Gewirtz

Streamlining pharmaceutical processes to increase global access to health care
Jan. 30, 2018

Jason Reed, Ph.D.
Assistant Professor
Department of Physics
Virginia Commonwealth University
Richmond, VA  23298

Host:  Dr. David Gewirtz

High-Speed Live Cell Interferometry:  A New Method for Rapidly Quantifying Tumor Drug Resistance and Heterogeneity
Feb. 6, 2018



Feb. 13, 2018

Sandro da Rocha, Ph.D.
Associate Professor
Department of Chemical and Life Sciences Engineering
Virginia Commonwealth University
Richmond, VA  23298

Host:  Dr. David Gewirtz

Dendrimer Nanocarriers for the Delivery of Therapeutics to and through the Lungs and their Potential in Repurposing Doxorubicin for Lung Cancer Treatment
Feb. 20, 2018

Gavril W. Pasternak, MD., Ph.D.
Anne Burnett Tandy Chair of Neurology
Memorial Sloan Kettering Cancer Center

Host:   Dr. Bill Dewey

Feb. 27, 2018


Mar. 6, 2018

Yavin Shaham, Ph.D.
Senior Investigator
Intramural Research Program
Branch Chief, Behavioral Neuroscience
Section Chief,  Neurobioloy of Relapse, NIDA
Baltimore, MD  21224

Host:  Dr. Matthew Banks

Incubation of drug craving after voluntary abstinence: behavior and circuit mechanisms
Mar. 13, 2018


Mar. 20, 2018

Robert L. Balster, Ph.D.
Virginia Commonwealth University
Department of Pharmacology and Toxicology
Richmond, VA  23298

Is nicotine vaping part of the solution to tobacco-related death and disease, or part of the problem?
Mar. 27, 2018

Ku-Lung Hsu, Ph.D.
Assistant Professor of Chemistry
University of Virginia
Charlottesville, VA  22904

Host:   Dr. Aron Lichtman

Chemoproteomic Strategies to Decode Metabolic Regulation of Lipid Signaling
Apr. 3, 2018

Joel Schlosburg, Ph.D.
Assistant Professor
Department of Pharmacology and Toxicology
Virginia Commonwealth University
Richmond, VA  23298


“Utilizing Mechanisms of Stress Resilience to  Slow the Progression of Addiction”
April 10, 2018

Luni Emdad, Ph.D.
Department of Human Genetics
Virginia Commonwealth University
Richmond, VA  23298

Host:  Dr. David Gewirtz

"Novel Strategy for the Therapy of Pancreatic Cancer" 
Apr. 17, 2018 Rujun Gong, Ph.D.
Associate Professor
Director of Kidney Research at the Nephrology Division
Brown University
Providence, RI  02912

Host:  Dr. Ningjun Li
"Therapeutic targeting of GSK3b in kidney disease"
April 30, 2018 

Special Seminar

Kathryn Cunningham, Ph.D.
Chauncey Leake Distinguished Professor of Pharmacology
Director, Center for Addiction Research
Vice Chair, Department of Pharmacology & Toxicology
University of Texas Medical Branch
Galveston, TX  77555

Host:   Dr. Bill Dewey

"Serotonin Matters in Addiction:  Strategies for Pharmacotherapeutics"
May 15, 2018  

 Matt Buczynski, Ph.D.

Assistant Professor
School of Neuroscience
Virginia Tech University
Blacksburg, VA

Host:  Dr. Joel Schlosburg

"The Role of Endocannabinoid Signaling Pathways in Nicotine Addiction" 
May 22, 2018

Student-invited speaker

Ken Mackie, Ph.D.
Department of Psychological and Brain Sciences and Program in Neuroscience
Indiana University, Bloomington
Bloomington, Indiana  47405

Host:  PHTX Grad Students

“THC, GPR119, and obesity”